Measurement of fasting insulin and glucose concentrations and their calculation of their product HOMA-IR might seem more attractive direct tools to measure insulin sensitivity in subjects with NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.